Antibiomania after triple therapy for Helicobacter Pylori

triple therapy  A standard bismuth quadruple therapy, a fluoroquinolone-containing triple therapy or a proton pump inhibitor Triple therapy and methotrexate‐based biologic disease‐modifying antirheumatic drug combinations were superior to methotrexate alone

A levofloxacin–amoxycillin-based triple therapy has been proved to be an acceptably effective second-line therapy for H pylori infection, but the role of Efficacy of Helicobacter pylori Eradication by Standard Triple Therapy in Patients with Chronic Idiopathic Thrombocytopenic Purpura in Pramongkutklao Hospital

Background: non-bismuth sequential therapy was suggested as a first-line anti-Helicobacter pylori treatment alternative to standard triple therapy Group C received oral moxifloxacin-based triple therapy for 14 days The results reported in this study indicated a significant